Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07094061 · ClinicalTrials.gov registry record · NA
Neurobehavioral Signatures of Sign- and Goal-Tracking in Emerging Adults: Translation of a Preclinical Model
A NA study of Healthy and Substance Use, sponsored by University of Michigan.
- Recruiting
- Registry status
- NA
- Development phase
- 294
- Enrollment target
- 2
- Study locations
NCT07094061: Recruiting NA study of Healthy and Substance Use, sponsored by University of Michigan.
NCT07094061 is a NA study of Healthy and Substance Use that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 294 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (55% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07094061, a NA study of Healthy and Substance Use, is actively recruiting participants, sponsored by University of Michigan.
- RECRUITING
- Registry status
- NA
- Development phase
- 294 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study seeks to understand individual differences in personality, brain function, and behavior. Study hypothesis: \- A stronger sign-tracking bias will be associated with a bottom-up processing style characterized by less adaptive attentional- and impulse-control as well as hyperactive reward processing, whereas a stronger goal-tracking bias will be associated with a top-down processing style characterized by strong attentional- and impulse-control as well as normative reward processing.
Primary Outcome
PavCA bias score based on eye gaze during the Pavlovian conditioned approach task will be correlated with a cannabis use composite score based on the Substance Use History and Timeline Follow-Back.
Conditions Studied
Interventions
- DEVICE fMRI
- BEHAVIORAL Questionnaires and surveys
- BEHAVIORAL Behavioral tasks and eye tracking
Study Locations (2)
Michigan
- Rachel Upjohn Building - Ann Arbor
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 294 participants |
| Start Date | 2025-10-03 |
| Est. Completion | 2027-10 |
| Phase | NA |
What NCT07094061 shows while recruiting
NCT07094061 is an interventional study that assigns participants to a tested intervention. The registered 294 participants enrollment target is mid-sized for trials with a published cap, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (55% lower).
The record links to 2 conditions, with Healthy appearing as the primary indexed condition, and to 3 interventions - of which fMRI is the first listed.
NCT07094061 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT07094061 about?
NCT07094061 is a clinical study titled "Neurobehavioral Signatures of Sign- and Goal-Tracking in Emerging Adults: Translation of a Preclinical Model". This study seeks to understand individual differences in personality, brain function, and behavior. Study hypothesis: \- A stronger sign-tracking bias will be associated with a bottom-up processing style characterized by less adaptive attentional- and impulse-control as well as hyperactive reward ...
What is the current status of trial NCT07094061?
This trial is currently recruiting. It is a NA study. The enrollment target is 294 participants. The study started on 2025-10-03. Estimated completion is 2027-10.
What conditions does trial NCT07094061 study?
This clinical trial studies the following conditions: Healthy, Substance Use.
What interventions are being tested in trial NCT07094061?
The interventions under investigation include: fMRI (DEVICE), Questionnaires and surveys (BEHAVIORAL), Behavioral tasks and eye tracking (BEHAVIORAL).
Who is sponsoring clinical trial NCT07094061?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07094061 being conducted?
This trial has 2 study locations across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07094061's enrollment target sits among peer trials
294 88th of 1090 higher than 1,003 of 1,090 other Healthy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
RECRUITING · NA
-
Oxalate and Citrate in Humans - Response to Citrate
RECRUITING · NA
-
CArdioMEtabolic Function and Reserve Capacity in Healthy Adults: The CAMERA Study
RECRUITING · NA
-
Examining Bronchial Hyperresponsiveness in Primary Ciliary Dyskinesia
RECRUITING · NA
-
Medical Illustration Design Characteristic Evaluation
RECRUITING · NA
-
Sodium vs Potassium Education to Improve Vascular Health
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05775159 · 294 participants · Phase 2
Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer
- NCT06262113 · 294 participants · NA
A Decentralized Clinical Trial to Promote Evidence-Based Care for Underserved Patients With Neurofibromatosis 1
- NCT06338865 · 294 participants · NA
Short Title: Standard vs. Lower Pressure Pneumoperitoneum
- NCT06395467 · 294 participants · NA
Integrated Treatment for Enhancing Growth in Recovery During Adolescence
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI